[Corrigendum] MicroRNA‑101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A
Oncology Letters · 20.08.2026 · 32 (4) · 1-3
DOI: 10.3892/ol.2026.15825 ↗Kurz gefasst
Korrektur in der Zeitschrift Oncology Letters, online erschienen am 20.08.2026. Verfasst von Lumin Wang und 6 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, L., Yao, J., Sun, H., He, K., Tong, D., Song, T., & Huang, C. (2026). [Corrigendum] MicroRNA‑101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A. Oncology Letters, 32(4), 1-3. https://doi.org/10.3892/ol.2026.15825
Vancouver
Wang L, Yao J, Sun H, He K, Tong D, Song T, et al. [Corrigendum] MicroRNA‑101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A. Oncology Letters. 2026;32(4):1-3. doi:10.3892/ol.2026.15825
BibTeX
@article{Wang2026,
author = {Wang, Lumin and Yao, Jiayi and Sun, Hongfei and He, Kang and Tong, Dongdong and Song, Tusheng and Huang, Chen},
title = {[Corrigendum] MicroRNA‑101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {4},
pages = {1--3},
doi = {10.3892/ol.2026.15825}
}
EUVIMED